DNA Nanoprobe Could Improve Oral Tumor Surgical Imaging
A new experimental DNA probe may help surgeons identify and remove oral tumors with greater precision in future clinical settings.
Updated on Oct. 15, 2026 in Cancer
Live Poll
Do you believe new molecular imaging technologies will make cancer surgery more successful in your lifetime?
Researchers have developed a 10-nanometer DNA-based nanoprobe capable of lighting up oral tumors to assist surgeons during resection in mice. This experimental technology aims to improve precision by creating visible fluorescence signals shortly after administration.
Why it matters
Enhancing tumor visibility during surgery is critical for ensuring complete tissue removal while sparing healthy surrounding structures. This research explores a new method to improve diagnostic and surgical precision, though the technology is currently limited to animal models.
This preclinical study utilized in vivo fluorescence analysis in a sample size of three mice to evaluate probe performance. While initial results show the 10-nanometer probe can produce signals within 10 to 30 minutes, systematic pathological assessments in larger animal models are pending.
The details
The nanoprobe utilizes a tetrahedral DNA structure designed for high biostability and efficient cellular uptake within tumor tissue. It functions via a target-responsive fluorescence switch: when the probe encounters specific molecules like nucleolin or microRNA-21, it detaches a detection strand, restoring its fluorescence. The 10-nanometer size is specifically engineered to minimize steric hindrance, allowing the probe to penetrate tumor tissue more effectively than larger molecules.
Timeline
10 minutes following intravenous injection for initial visible fluorescence.
30 minutes after local infiltration for detectable signals.
1 hour for in vitro fluorescence to reach 23 to 39 percent of maximum.
4 hours for fluorescence recovery to reach 43 to 72 percent.
2 weeks for the duration of post-surgical animal monitoring.
Health Landscape
Fluorescence-guided surgery is an established area of medical imaging intended to help surgeons differentiate malignant tissue from healthy areas in real time. This research represents an evolution in these techniques by miniaturizing the contrast agents to the nanoscale.
This development is in the preclinical stage and is not currently available for patient care. It is important to discuss any surgical or diagnostic questions regarding oral health with your physician or an oncology specialist.
The takeaway
DNA nanotechnology may one day offer a new way to guide tumor removal by making cancerous tissue easier to visualize. Readers concerned about oral health should focus on routine screenings and consult their primary care physician about any persistent symptoms.
Further reading
Learn more about new diagnostic advancements in our Cancer section.
Source note: This article includes information reported by AZoNano.
Live Poll
Do you believe new molecular imaging technologies will make cancer surgery more successful in your lifetime?
